Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT
NCT ID: NCT01104064
Last Updated: 2013-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
19 participants
INTERVENTIONAL
2010-02-28
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Aim #1: Examine the safety of five treatments of 6-Hz primed low-frequency rTMS alternating with five treatments of CIT in children with hemiplegia.
Adverse effects will be measured through observation for seizures, continual physician screening, evaluation of cognitive function and motor function in the nonparetic hand. The working hypothesis is:
1\. Five 6-Hz primed low-frequency rTMS treatments combined with CIT will not produce any seizure activity nor any other serious adverse effect.
Specific Aim #2. Determine the synergistic effect of rTMS combined with CIT on functional outcomes in children with hemiplegia.
Fifteen children with hemiplegia at each of two pediatric medical centers (total N=30) will be randomly assigned in equal numbers to one of two groups: rTMSreal/CIT, rTMSsham/CIT. The working hypotheses are:
1. Both groups will show significant improvement in functional outcomes in the paretic hand at posttest compared to their pretest.
2. The rTMSreal/CIT group will show significantly greater improvement in function in the paretic hand compared to the rTMSsham/CIT group.
Specific Aim #3: Explore the brain reorganization associated with 6-Hz primed low-frequency rTMS combined with CIT.
Treatment-induced brain reorganization in the ipsilesional hemisphere will be explored with evoked cortical excitability, using TMS for paired-pulse testing and cortical silent period testing, as well as with voluntary cortical recruitment using functional magnetic resonance imaging (fMRI). The working hypotheses are:
1. Both groups will show significantly greater responses with TMS testing and fMRI testing at posttest compared to their pretest.
2. The rTMSreal/CIT group will show significantly greater changes compared to the rTMSsham/CIT group.
This research is innovative in that it combines a unique form of noninvasive brain stimulation (primed low-frequency rTMS) with behavioral training (CIT) to promote a synergism that could achieve higher recovery in pediatric hemiplegia than through either treatment alone. The expected outcomes are improved hand function with no adverse effects leading to improved quality of life and reduced burden of care across the lifespan of children with hemiplegia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real rTMS combined with CIT
real rTMS combined with constraint induced therapy
10 minutes of priming followed by 10 minutes of low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.
Sham rTMS combined with CIT
sham rTMS combined with constraint induced therapy
10 minutes of sham priming followed by 10 minutes of sham low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
real rTMS combined with constraint induced therapy
10 minutes of priming followed by 10 minutes of low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.
sham rTMS combined with constraint induced therapy
10 minutes of sham priming followed by 10 minutes of sham low-frequency is followed on the next day with constraint induced therapy. A total of 5 treatment days for each therapy is given.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to see whether a computer screen cursor is slightly above/below a target line,
* ability to understand finger tracking test evidenced by a score above 0,
* evidence of an MEP in paretic hand muscle with TMS testing of ipsilesional M1, age-equivalent receptive language function.
Exclusion Criteria
* neoplasm,
* seizures,
* disorders of cellular migration and proliferation,
* lack of age appropriate receptive language function,
* expressive aphasia,
* pregnancy,
* claustrophobia,
* indwelling metal or MRI incompatible medical devices,
* gross visual field cuts.
8 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James R Carey, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gillick BT, Krach LE, Feyma T, Rich TL, Moberg K, Menk J, Cassidy J, Kimberley T, Carey JR. Safety of primed repetitive transcranial magnetic stimulation and modified constraint-induced movement therapy in a randomized controlled trial in pediatric hemiparesis. Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S104-13. doi: 10.1016/j.apmr.2014.09.012. Epub 2014 Oct 2.
Gillick BT, Krach LE, Feyma T, Rich TL, Moberg K, Thomas W, Cassidy JM, Menk J, Carey JR. Primed low-frequency repetitive transcranial magnetic stimulation and constraint-induced movement therapy in pediatric hemiparesis: a randomized controlled trial. Dev Med Child Neurol. 2014 Jan;56(1):44-52. doi: 10.1111/dmcn.12243. Epub 2013 Aug 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pediatric Hemiplegia and rTMS
Identifier Type: -
Identifier Source: org_study_id